Dow Today: Visa (V) Leads The Day Higher, Johnson & Johnson (JNJ) Lags

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

The Dow Jones Industrial Average ( ^DJI) closed up 71 points (+0.5%) at 15,821. The NYSE advances/declines ratio closed at 2,061 issues advancing vs. 948 declining with 106 unchanged.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

The Dow component that led the way higher today was Visa (NYSE: V), which sported a $1.91 gain (+1%) bringing the stock to $199.78. This single gain lifted the Dow Jones Industrial Average by 14.46 points or roughly accounting for 20.4% of the Dow's overall gain. Volume for Visa ended the day at two million shares traded vs. an average daily trading volume of 3.2 million shares.

Visa has a market cap of $102.54 billion and is part of the financial sector and financial services industry. Shares are up 30.8% year to date as of Tuesday's close. The stock's dividend yield sits at 0.8%.

Visa Inc., a payments technology company, engages in the operation of retail electronic payments network worldwide. It facilitates commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities. The company has a P/E ratio of 26.3, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Visa as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

Holding the Dow back today was Johnson & Johnson (NYSE: JNJ), which lagged the broader Dow index with a 21-cent decline (-0.2%) bringing the stock to $93.35. Volume for Johnson & Johnson ended the day at 7.4 million shares traded vs. an average daily trading volume of 7.6 million shares.

Johnson & Johnson has a market cap of $266.03 billion and is part of the health care sector and drugs industry. Shares are up 34.5% year to date as of Tuesday's close. The stock's dividend yield sits at 2.8%.

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics. The company has a P/E ratio of 21, above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Johnson & Johnson as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, reasonable valuation levels and good cash flow from operations. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
null

If you liked this article you might like

Sneaky Rally; Wells Fargo Needs Outside Help -- Jim Cramer's Top Thoughts

Apple Is the Tom Brady of Stocks: Cramer's 'Mad Money' Recap (Thursday 8/31/17)

Cramer: Fantasy Shmantasy -- Let's Get Real With These Stock Picks

Visa, MasterCard, Discover Offer Secured Credit Cards, a Tool for College Kids

Cognizant Technology, Advanced Micro Devices: 'Mad Money' Lightning Round